Dr Vicky Marshall

  • Clinical supervisor (School of Psychology & Neuroscience)

email: Vicky.Marshall@glasgow.ac.uk

3rd floor Neurology, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 2TF

Import to contacts

Publications

List by: Type | Date

Jump to: 2024 | 2006 | 2005 | 2003
Number of items: 7.

2024

Gandhi, S. E. et al. (2024) Motor complications in Parkinson's disease: results from 3343 patients followed for up to 12 years. Movement Disorders Clinical Practice, 11(6), pp. 686-697. (doi: 10.1002/mdc3.14044) (PMID:38587023)

2006

Marshall, V. L., Patterson, J., Hadley, D. M., Grosset, K. A. and Grosset, D. G. (2006) Successful Antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP-CIT SPECT. Movement Disorders, 21(12), pp. 2247-2250. (doi: 10.1002/mds.21159) (PMID:17078059)

Marshall, V. L., Patterson, J., Hadley, D. M., Grosset, K. A. and Grosset, D. G. (2006) Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging. Nuclear Medicine Communications, 27(12), pp. 933-937. (doi: 10.1097/01.mnm.0000243374.11260.5b)

2005

Marshall, V. and Grosset, D. (2005) Reply: the meaning of negative DAT and F‐Dopa PET scans in a patient with clinical Parkinson's disease. Movement Disorders, p. 118. (doi: 10.1002/mds.20313)

2003

Marshall, V. and Grosset, D. (2003) Role of dopamine transporter imaging in routine clinical practice. Movement Disorders, 18(12), pp. 1415-1423. (doi: 10.1002/mds.10592) (PMID:14673877)

Marshall, V. and Grosset, D. G. (2003) Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders. Movement Disorders, 18(S7), S22-S27. (doi: 10.1002/mds.10574) (PMID:14531042)

Marshall, V.L. and Grosset, D.G. (2003) Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology, 61(6), p. 871. (doi: 10.1212/WNL.61.6.871) (PMID:14504352)

This list was generated on Wed Dec 18 12:38:41 2024 GMT.
Jump to: Articles
Number of items: 7.

Articles

Gandhi, S. E. et al. (2024) Motor complications in Parkinson's disease: results from 3343 patients followed for up to 12 years. Movement Disorders Clinical Practice, 11(6), pp. 686-697. (doi: 10.1002/mdc3.14044) (PMID:38587023)

Marshall, V. L., Patterson, J., Hadley, D. M., Grosset, K. A. and Grosset, D. G. (2006) Successful Antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP-CIT SPECT. Movement Disorders, 21(12), pp. 2247-2250. (doi: 10.1002/mds.21159) (PMID:17078059)

Marshall, V. L., Patterson, J., Hadley, D. M., Grosset, K. A. and Grosset, D. G. (2006) Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging. Nuclear Medicine Communications, 27(12), pp. 933-937. (doi: 10.1097/01.mnm.0000243374.11260.5b)

Marshall, V. and Grosset, D. (2005) Reply: the meaning of negative DAT and F‐Dopa PET scans in a patient with clinical Parkinson's disease. Movement Disorders, p. 118. (doi: 10.1002/mds.20313)

Marshall, V. and Grosset, D. (2003) Role of dopamine transporter imaging in routine clinical practice. Movement Disorders, 18(12), pp. 1415-1423. (doi: 10.1002/mds.10592) (PMID:14673877)

Marshall, V. and Grosset, D. G. (2003) Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders. Movement Disorders, 18(S7), S22-S27. (doi: 10.1002/mds.10574) (PMID:14531042)

Marshall, V.L. and Grosset, D.G. (2003) Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology, 61(6), p. 871. (doi: 10.1212/WNL.61.6.871) (PMID:14504352)

This list was generated on Wed Dec 18 12:38:41 2024 GMT.